The evolution of SARS-CoV-2 in the past year has been remarkable with Delta increasing transmissibility by perhaps 2.2X over "non-variant" viruses. 1/14
We should expect this evolution to slow as SARS-CoV-2 continues to adapt to the human host, but when should we expect this? Here, I propose that we've already seen slowing between 2020 and today. 2/14
One very important concept here that I keep coming back to in thinking about evolution is @GreatDismal's quote that "the future is already here. It's just not evenly distributed yet". 3/14
At this point, basically all circulating SARS-CoV-2 is Delta. However, Delta viruses arose in close to current form back around ~Oct 2020 (nextstrain.org/groups/blab/nc…). 4/14
This ~Oct 2020 virus would have existed in a single person, and even though this virus would have been significantly more transmissible back in ~Oct 2020, it still takes ~9 months of exponential growth for descendants of this single infection to become globally predominant. 5/14
The SARS-CoV-2 future existed in ~Oct 2020, it just wasn't very evenly distributed. 6/14
In work with @KateKistler and @huddlej, we found that the S1 region of the spike protein appears to be the focus of adaptive evolution in SARS-CoV-2, where S1 mutations are associated with more evolutionarily successful viruses. 7/14
If we look at the evolution of S1 in Delta viruses we can see a rapid accumulation of S1 substitutions from ~Mar 2020 to ~Oct 2020 and then relative stasis after this point. 8/14
The yellow lineage tracks Delta viruses. In ~Oct 2020 Delta has 7 S1 mutations relative to non-variant circulating viruses with 1 to 3 S1 mutations. But from ~Oct 2020 to today there has been few additional changes in S1 in Delta viruses (nextstrain.org/groups/blab/nc…). 9/14
This accumulation of S1 mutations in mid-2020 can be seen across different variant viruses. This is Figure S5 from Kistler et al. (bedford.io/papers/kistler…). 10/14
We're left with a dynamic in which variant viruses mutate into existence over the course of 2020, are initially rare, but appear to burst onto the scene in early 2021 due to exponential growth. Competition over the course of 2021 leaves only Delta viruses standing. 11/14
This results in this picture of S1 mutations in sampled viruses where the spread of variant viruses in early 2021 causes a rapid increase in S1 mutations in the population. But after the sweep of Delta in July 2021, S1 accumulation in the population has basically ceased. 12/14
I highly doubt that SARS-CoV-2 has hit a wall in terms of its evolutionary potential, but I do think it's safe to conclude that evolution, at least in terms of S1, has been slowing in the past year and a half. 13/14
Although evolution may be slowing, based on rapidity to date, I still anticipate with rising population immunity that we'll see a shift in evolutionary pressure towards immune escape and at endemicity the virus will undergo continual antigenic drift. 14/14
I support making boosters broadly available for those 18 and older. Even if breakthrough cases are generally mild in younger age groups, there is significant societal benefit to reducing circulation. 1/6 nytimes.com/2021/11/16/us/…
Currently Washington State is seeing almost 30% of cases as breakthrough cases (doh.wa.gov/Portals/1/Docu…). 2/6
Here, I think of @alexismadrigal's piece on the implications of a positive COVID test (theatlantic.com/health/archive…). It's crazy to me that we're saying to healthy younger individuals they must isolate for 10 days after a positive test, but that they're not eligible for a booster. 3/6
I've meaning to write a "COVID endgame" thread for a while and I apologize this is somewhat delayed compared to media interviews like science.org/content/articl… and statnews.com/2021/09/20/win… and to recent seminars like . 1/17
Here, I've been trying to think about what COVID will look like in its endemic state, ie once the (more or less entire) population has immunity to the virus, blunting transmission and disease relative to the pandemic state. 2/17
I expect endemicity to be achieved at different times throughout the world due to inequities in vaccine distribution and I expect this to be a soft transition rather than a sudden flip of a switch. 3/17
I realize this is rather late to the party, but I wanted to provide a look at the prospects of Mu variant virus. I believe we can conclude that Mu appears more transmissible than all circulating variants except for Delta, but Delta is substantially fitter than Mu. 1/9
If we look within Colombia, we see Mu becoming predominant around May 2021, outcompeting other endogenous South American variants Gamma and Lambda. However, recent sequencing suggests that Delta is successfully invading on this Mu background (nextstrain.org/ncov/gisaid/so…). 2/9
In neighboring Ecuador, we see a heterogeneous mix of Alpha, Gamma, Iota, Lambda and Mu by June 2021. Delta has been successfully displacing most of this diversity since July 2021, while Mu has remained relatively stable (nextstrain.org/ncov/gisaid/so…). 3/9
I'm honored and completely overwhelmed by the recognition from @macfound and @HHMINEWS. Flexible funding with a multi-year commitment is the professional scientist's dream and I'm incredibly grateful for this opportunity. 1/4
For me, like others in the field, responding to the pandemic has been a ceaseless and exhausting endeavor. But I'm immensely proud of what the teams at @nextstrain, @fredhutch and the @seattleflustudy, as well as the larger scientific community, have accomplished. 2/4
That said, it's difficult for me to sort out my feelings about these awards, as they are so intertwined with the pandemic. It feels perhaps uncomfortable to be professionally rewarded for doing something that felt like a moral imperative. 3/4
New (not yet peer-reviewed) work by Katie Kistler and @huddlej in the lab assessing adaptive evolution in SARS-CoV-2 across the viral genome. 1/12 biorxiv.org/content/10.110…
We measure adaptive evolution by correlating mutations in different regions of the genome with growth of clade frequency. For this, we use a viral phylogeny of ~10k genomes sampled equitably through space and time across the pandemic (nextstrain.org/groups/blab/nc…). 2/12
If mutations to a region result in fitter viruses, clades bearing these mutations should expand more rapidly. We find that the S1 domain of spike accumulates protein-coding (nonsynonymous) changes rapidly and that clades with more S1 mutations tend to grow in frequency. 3/12
It looks like we're about at the peak of the Delta SARS-CoV-2 wave in the US (figure based on @CDCGov data). A thread on current circulation patterns and the impact of Delta. 1/14
This inflection point in case loads at the country-level is due to decline in some states (such as FL and LA) and growth in others (such as OH and WV). Figure shows cases per 100k population on a log axis to emphasis state-level growth and decline. 2/14
Using previously described method to split cases by variant frequency (
), we see a striking pattern in which most states have a moderate spring wave comprised of a mix of Alpha and other variants, but show a large Delta wave in the summer. 3/14